23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Pfizer Inc. › 2025-2026

Pfizer Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Pfizer Inc.’s Form 8-K, filed April 27, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 16Ballot items
  • 1,581Asset managers, any item
  • 19,278Fund votes
  • April 23, 2026Meeting date

Results at a glance

Meeting of April 23, 2026: 16 items on Pfizer Inc.’s Form 8-K, filed April 27, 2026: 12 elected · 3 approved · 1 not approved.

Dissent

Significant dissent: 1 shareholder proposal (28.8% support).

Notable dissent: 1 director (17.3% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Pfizer Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Pfizer Inc.

These tallies are Pfizer Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed April 27, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Pfizer Inc. — official shareholder meeting results, meeting held April 23, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Ronald E. Blaylock 3,442,653,662102,600,74811,374,500 --941,392,137 97%Elected—
Elect Director: Albert Bourla 3,261,211,737272,132,57323,284,563 --941,392,137 92%Elected—
Elect Director: Mortimer J. Buckley 3,403,974,675141,036,93211,617,303 --941,392,137 96%Elected—
Elect Director: Susan Desmond-Hellmann 3,401,932,807141,056,14713,639,956 --941,392,137 96%Elected—
Elect Director: Joseph J. Echevarria 2,929,511,380612,413,50214,702,274 --941,392,137 83%Elected—
Elect Director: Scott Gottlieb 3,415,886,776130,394,18510,343,738 --941,392,137 96%Elected—
Elect Director: Dan R. Littman 3,383,769,589161,740,87211,118,449 --941,392,137 95%Elected—
Elect Director: Shantanu Narayen 3,313,318,763231,613,93211,695,915 --941,392,137 93%Elected—
Elect Director: Suzanne Nora Johnson 3,272,936,863273,506,15110,185,896 --941,392,137 92%Elected—
Elect Director: James Quincey 3,453,778,74191,549,23611,300,933 --941,392,137 97%Elected—
Elect Director: James C. Smith 3,284,035,682261,217,69911,375,529 --941,392,137 93%Elected—
Elect Director: Cyrus Taraporevala 3,468,177,42376,665,72111,785,766 --941,392,137 98%Elected—
2. Proposal to ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the 2026 fiscal year 4,160,827,231321,979,09615,214,720 ---- 93%Approved—
3. Proposal to approve the Pfizer Inc. 2019 Stock Plan, as amended April 2026 3,227,692,578305,428,37623,507,956 --941,392,137 91%Approved—
4. Proposal to approve, on an advisory basis, the 2026 compensation of the Company's Named Executive Officers 3,099,249,442423,935,88133,443,287 --941,392,137 88%Approved—
5. Shareholder proposal to Adopt An Independent Chair Policy 1,015,206,3722,509,042,02132,354,566 --941,392,137 29%Not approved—

Source: Pfizer Inc., Form 8-K, filed with the SEC on April 27, 2026 — read the filing on EDGAR.

How asset managers voted at the Pfizer Inc. 2025-2026 meeting

1,581 asset managers disclosed a vote on at least one Pfizer Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Ronald E. Blaylock

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 3,442,653,662AGAINST: 102,600,748

Prior year: 96.1% for (April 24, 2025 meeting) ▲ 1.0 pts

Details: description as filed, official tally, votes by 231 asset managers

Description as filed by funds: Election of Directors: Ronald E. Blaylock

Pfizer Inc.’s own tally for this item (“Elect Director: Ronald E. Blaylock”): 3,442,653,662 for, 102,600,748 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following v…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 1,257,363,993 for, 2,677,560 against, 285,296 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,257,363,993AGAINST: 2,677,560ABSTAIN: 285,296UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Election of Directors: Ronald E. Blaylock” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard513,493,433542 550For
BlackRock170,809,0010 00For
Fidelity119,044,3500 00For
State Street66,831,1250 00For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,756,2210 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 231 asset managers. All 231 are in the interactive database (link above).

Elect Director: Albert Bourla

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%
FOR: 3,261,211,737AGAINST: 272,132,573

Prior year: 91.4% for (April 24, 2025 meeting) ▲ 0.9 pts

Details: description as filed, official tally, votes by 231 asset managers

Description as filed by funds: Election of Directors: Albert Bourla

Pfizer Inc.’s own tally for this item (“Elect Director: Albert Bourla”): 3,261,211,737 for, 272,132,573 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following v…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 1,259,727,449 for, 274,104 against, 285,291 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,259,727,449AGAINST: 274,104ABSTAIN: 285,291UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Election of Directors: Albert Bourla” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard513,492,5311,444 500For
BlackRock170,809,0010 00For
Fidelity119,044,3500 00For
State Street66,830,599526 00For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,756,2210 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 231 asset managers. All 231 are in the interactive database (link above).

Elect Director: Mortimer J. Buckley

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 3,403,974,675AGAINST: 141,036,932

Prior year: 97.1% for (April 24, 2025 meeting) ▼ 1.1 pts

Details: description as filed, official tally, votes by 231 asset managers

Description as filed by funds: Election of Directors: Mortimer J. Buckley

Pfizer Inc.’s own tally for this item (“Elect Director: Mortimer J. Buckley”): 3,403,974,675 for, 141,036,932 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following v…”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 1,257,141,792 for, 2,859,759 against, 285,296 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,257,141,792AGAINST: 2,859,759ABSTAIN: 285,296UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Election of Directors: Mortimer J. Buckley” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard513,493,219754 550For
BlackRock170,809,0010 00For
Fidelity119,044,3500 00For
State Street66,831,1250 00For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,756,2210 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 231 asset managers. All 231 are in the interactive database (link above).

Elect Director: Susan Desmond-Hellmann

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 3,401,932,807AGAINST: 141,056,147

Prior year: 96.7% for (April 24, 2025 meeting) ▼ 0.7 pts

Details: description as filed, official tally, votes by 231 asset managers

Description as filed by funds: Election of Directors: Susan Desmond-Hellmann

Pfizer Inc.’s own tally for this item (“Elect Director: Susan Desmond-Hellmann”): 3,401,932,807 for, 141,056,147 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following v…”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 1,253,544,750 for, 6,337,277 against, 404,822 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,253,544,750AGAINST: 6,337,277ABSTAIN: 404,822UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Election of Directors: Susan Desmond-Hellmann” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard512,916,987576,974 690For
BlackRock170,709,65999,342 00For
Fidelity119,044,3500 00For
State Street66,713,0500 118,0750For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,756,2210 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 231 asset managers. All 231 are in the interactive database (link above).

Elect Director: Joseph J. Echevarria

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST
FOR: 2,929,511,380AGAINST: 612,413,502

Prior year: 89.0% for (April 24, 2025 meeting) ▼ 6.3 pts

Details: description as filed, official tally, votes by 231 asset managers

Description as filed by funds: Election of Directors: Joseph J. Echevarria

Pfizer Inc.’s own tally for this item (“Elect Director: Joseph J. Echevarria”): 2,929,511,380 for, 612,413,502 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following v…”
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 1,167,700,504 for, 92,299,689 against, 286,653 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,167,700,504AGAINST: 92,299,689ABSTAIN: 286,653UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Election of Directors: Joseph J. Echevarria” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard513,090,627403,326 750For
BlackRock170,746,18062,821 00For
Fidelity117,264,9501,779,400 00For
State Street66,831,1250 00For
Charles Schwab41,130,3129,752 00For
MFS033,995,774 00Against
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds017,000,000 00Against
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National8,847,166469,897 00Mixed
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle08,640,388 00Against
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI04,756,221 00Against
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 231 asset managers. All 231 are in the interactive database (link above).

Elect Director: Scott Gottlieb

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 3,415,886,776AGAINST: 130,394,185

Prior year: 98.0% for (April 24, 2025 meeting) ▼ 1.7 pts

Details: description as filed, official tally, votes by 231 asset managers

Description as filed by funds: Election of Directors: Scott Gottlieb

Pfizer Inc.’s own tally for this item (“Elect Director: Scott Gottlieb”): 3,415,886,776 for, 130,394,185 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following v…”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 1,255,059,664 for, 4,773,199 against, 453,983 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,255,059,664AGAINST: 4,773,199ABSTAIN: 453,983UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Election of Directors: Scott Gottlieb” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard512,917,093576,885 490For
BlackRock170,709,65999,342 00For
Fidelity119,044,3500 00For
State Street66,713,0500 118,0750For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,756,2210 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 231 asset managers. All 231 are in the interactive database (link above).

Elect Director: Shantanu Narayen

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 3,313,318,763AGAINST: 231,613,932

Prior year: 97.7% for (April 24, 2025 meeting) ▼ 4.2 pts

Details: description as filed, official tally, votes by 231 asset managers

Description as filed by funds: Election of Directors: Shantanu Narayen

Pfizer Inc.’s own tally for this item (“Elect Director: Shantanu Narayen”): 3,313,318,763 for, 231,613,932 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following v…”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 1,254,940,654 for, 4,922,481 against, 404,708 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,254,940,654AGAINST: 4,922,481ABSTAIN: 404,708UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Election of Directors: Shantanu Narayen” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard512,916,501577,468 550For
BlackRock170,709,65999,342 00For
Fidelity118,351,650692,700 00For
State Street66,711,9341,117 118,0750For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,756,2210 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 231 asset managers. All 231 are in the interactive database (link above).

Elect Director: Suzanne Nora Johnson

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%
FOR: 3,272,936,863AGAINST: 273,506,151

Prior year: 93.6% for (April 24, 2025 meeting) ▼ 1.3 pts

Details: description as filed, official tally, votes by 231 asset managers

Description as filed by funds: Election of Directors: Suzanne Nora Johnson

Pfizer Inc.’s own tally for this item (“Elect Director: Suzanne Nora Johnson”): 3,272,936,863 for, 273,506,151 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following v…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 1,255,882,805 for, 4,098,414 against, 286,626 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,255,882,805AGAINST: 4,098,414ABSTAIN: 286,626UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Election of Directors: Suzanne Nora Johnson” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard513,492,6021,377 480For
BlackRock170,776,24932,752 00For
Fidelity118,351,650692,700 00For
State Street66,830,0081,117 00For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,756,2210 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 231 asset managers. All 231 are in the interactive database (link above).

Elect Director: James Quincey

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 3,453,778,741AGAINST: 91,549,236

Prior year: 96.1% for (April 24, 2025 meeting) ▲ 1.3 pts

Details: description as filed, official tally, votes by 231 asset managers

Description as filed by funds: Election of Directors: James Quincey

Pfizer Inc.’s own tally for this item (“Elect Director: James Quincey”): 3,453,778,741 for, 91,549,236 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following v…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 1,255,829,329 for, 4,033,811 against, 404,708 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,255,829,329AGAINST: 4,033,811ABSTAIN: 404,708UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Election of Directors: James Quincey” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard512,917,277576,697 550For
BlackRock170,709,65999,342 00For
Fidelity119,044,3500 00For
State Street66,713,0500 118,0750For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,756,2210 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 231 asset managers. All 231 are in the interactive database (link above).

Elect Director: Cyrus Taraporevala

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 3,468,177,423AGAINST: 76,665,721

Prior year: 97.0% for (April 24, 2025 meeting) ▲ 0.8 pts

Details: description as filed, official tally, votes by 231 asset managers

Description as filed by funds: Election of Directors: Cyrus Taraporevala

Pfizer Inc.’s own tally for this item (“Elect Director: Cyrus Taraporevala”): 3,468,177,423 for, 76,665,721 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following v…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 231 asset managers below reported 1,259,298,453 for, 684,098 against, 285,296 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,259,298,453AGAINST: 684,098ABSTAIN: 285,296UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Election of Directors: Cyrus Taraporevala” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard513,493,573400 550For
BlackRock170,809,0010 00For
Fidelity119,044,3500 00For
State Street66,831,1250 00For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,756,2210 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 231 asset managers. All 231 are in the interactive database (link above).

Elect Director: Dan R. Littman

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 3,383,769,589AGAINST: 161,740,872

Prior year: 95.6% for (April 24, 2025 meeting) ▼ 0.2 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: Election of Directors: Dan R. Littman

Pfizer Inc.’s own tally for this item (“Elect Director: Dan R. Littman”): 3,383,769,589 for, 161,740,872 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following v…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 1,254,408,212 for, 5,577,090 against, 285,293 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,254,408,212AGAINST: 5,577,090ABSTAIN: 285,293UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Election of Directors: Dan R. Littman” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard513,493,113860 520For
BlackRock170,809,0010 00For
Fidelity119,044,3500 00For
State Street66,831,1250 00For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,756,2210 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Elect Director: James C. Smith

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 3,284,035,682AGAINST: 261,217,699

Prior year: 93.7% for (April 24, 2025 meeting) ▼ 1.0 pts

Details: description as filed, official tally, votes by 230 asset managers

Description as filed by funds: Election of Directors: James C. Smith

Pfizer Inc.’s own tally for this item (“Elect Director: James C. Smith”): 3,284,035,682 for, 261,217,699 against, per its Form 8-K filed April 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following v…”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 230 asset managers below reported 1,255,649,339 for, 4,315,627 against, 286,633 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,255,649,339AGAINST: 4,315,627ABSTAIN: 286,633UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Election of Directors: James C. Smith” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard513,492,6321,342 550For
BlackRock170,809,0010 00For
Fidelity118,351,650692,700 00For
State Street66,830,0081,117 00For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,756,2210 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 230 asset managers. All 230 are in the interactive database (link above).

Proposal to approve the Pfizer Inc. 2019 Stock Plan, as amended April 2026

Official resultCAPITAL STRUCTUREReported outcome: Approved

Combines 13 wordings of this item as funds reported it.

91% Approved · of votes cast

FOR 91%
FOR: 3,227,692,578AGAINST: 305,428,376
Details: description as filed, official tally, votes by 257 asset managers

Description as filed by funds: Approval of the Pfizer Inc. 2019 Stock Plan, as amended April 2026

Pfizer Inc.’s own tally for this item (“3. Proposal to approve the Pfizer Inc. 2019 Stock Plan, as amended April 2026”): 3,227,692,578 for, 305,428,376 against — passed, per its Form 8-K filed April 27, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: The proposal to approve the Pfizer Inc. 2019 Stock Plan, as amended April 2026 was approved based upon the following votes”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 257 asset managers below reported 1,257,572,346 for, 5,354,546 against, 285,898 abstained, 4,323 not voted, 14,641 unknown.

FOR
FOR: 1,257,572,346AGAINST: 5,354,546ABSTAIN: 285,898UNKNOWN: 14,641NOT VOTED: 4,323
Largest asset managers voting on “Approval of the Pfizer Inc. 2019 Stock Plan, as amended April 2026” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard512,916,074577,835 1200For
BlackRock170,709,65999,342 00For
Fidelity118,839,575204,775 00For
State Street66,712,524118,601 00For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 5370For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,619,715136,506 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 257 asset managers. All 257 are in the interactive database (link above).

Proposal to approve, on an advisory basis, the 2026 compensation of the Company's Named Executive Officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 30 wordings of this item as funds reported it.

88% Approved · of votes cast

FOR 88%
FOR: 3,099,249,442AGAINST: 423,935,881

Prior year: 54.7% for (April 24, 2025 meeting) ▲ 33.3 pts

Details: description as filed, official tally, votes by 1,573 asset managers

Description as filed by funds: Advisory approval of named executive officer compensation

Pfizer Inc.’s own tally for this item (“4. Proposal to approve, on an advisory basis, the 2026 compensation of the Company's Named Executive Officers”): 3,099,249,442 for, 423,935,881 against — passed, per its Form 8-K filed April 27, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4: The proposal to approve, on an advisory basis, the 2026 compensation of the Company's Named Executive Officers was approved based upon the following votes”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Pfizer Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Say on Pay” (8 managers, 5,550,610 for, 333 against).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 217 asset managers voting on “Advisory approval of named executive officer compensation” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard513,091,660402,196 1750For
BlackRock170,776,24932,752 00For
Fidelity118,351,650692,700 00For
State Street66,830,0081,117 00For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA012,223,514 00Against
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,756,2210 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Fund voting reports, all 217 managers: 1,234,936,610 for, 23,974,281 against, 318,379 abstained, 4,324 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1,390 asset managers voting on “Advisory approval of named executive officer compensation” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock247,146,085466,049 00For
State Street166,485,1071,626,561 00For
GEODE CAPITAL MANAGEMENT, LLC131,950,1080 00For
Fisher Asset Management, LLC87,969,7460 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/64,164,0310 00For
Vanguard59,175,2710 00For
Northern Trust51,823,787438,570 00For
Charles Schwab50,851,9250 00For
Wellington44,078,1930 00For
Amundi043,225,546 00Against
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO41,402,0350 00For
Invesco32,349,0640 00For
MELLON INVESTMENTS Corp27,609,3160 00For
Legal & General Investment Management Ltd578,82526,360,418 00Against
Capital Group22,791,7970 5370For
FRANKLIN ADVISERS INC22,746,1590 00For
T. Rowe Price21,530,0180 00For
Goldman Sachs21,152,2750 00For
Federated Hermes18,609,7950 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC017,334,675 00Against
UBS14,992,8421,356,221 00Mixed
Unisphere Establishment14,650,0000 00For
RBC Capital Markets, LLC14,606,3810 00For
Fidelity4,379,9588,651,705 00Mixed
Nuveen013,021,959 00Against

Institutional-manager reports, all 1,390 managers: 1,745,355,921 for, 261,951,604 against, 4,093 withheld, 9,615,665 abstained, 568,343 not voted, 14,641 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Proposal to ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 9 wordings of this item as funds reported it.

93% Approved · of votes cast

FOR 93%
FOR: 4,160,827,231AGAINST: 321,979,096

Prior year: 93.3% for (April 24, 2025 meeting) ▼ 0.5 pts

Details: description as filed, official tally, votes by 231 asset managers

Description as filed by funds: Ratify the selection of KPMG LLP as our independent registered public accounting firm for 2026

Pfizer Inc.’s own tally for this item (“2. Proposal to ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the 2026 fiscal year”): 4,160,827,231 for, 321,979,096 against — passed, per its Form 8-K filed April 27, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2: The proposal to ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the 2026 fiscal year was approved based upon the following votes”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Pfizer Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (8 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 231 asset managers below reported 1,256,907,837 for, 971,572 against, 285,281 abstained, 4,323 not voted.

FOR
FOR: 1,256,907,837AGAINST: 971,572ABSTAIN: 285,281NOT VOTED: 4,323
Largest asset managers voting on “Ratify the selection of KPMG LLP as our independent registered public accounting firm for 2026” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard513,092,337401,654 400For
BlackRock170,776,24932,752 00For
Fidelity119,044,3500 00For
State Street66,830,0081,117 00For
Charles Schwab41,140,0640 00For
MFS33,995,7740 00For
Invesco20,894,3500 00For
Dimensional19,353,9200 00For
First Trust18,739,1360 00For
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust16,351,6300 00For
Hartford14,606,3910 00For
TIAA12,223,5140 00For
Federated Hermes10,850,0370 00For
Jackson National9,317,0630 00For
MASTER INVESTMENT PORTFOLIO8,775,0490 00For
Columbia Threadneedle8,640,3880 00For
BNY Mellon6,239,6650 00For
Neuberger Berman5,858,3610 00For
T. Rowe Price4,936,6910 00For
SEI4,619,715136,506 00For
Six Circles Trust4,675,3190 00For
Voya4,509,0010 00For
WisdomTree4,217,0230 00For

Showing the 25 largest of 231 asset managers. All 231 are in the interactive database (link above).

Shareholder proposal to Adopt An Independent Chair Policy

Official resultCORPORATE GOVERNANCEReported outcome: Not approved

Combines 8 wordings of this item as funds reported it.

29% Not approved · of votes cast

FOR 29%AGAINST
FOR: 1,015,206,372AGAINST: 2,509,042,021
Details: description as filed, official tally, votes by 233 asset managers

Description as filed by funds: Adopt an Independent Chair Policy

Pfizer Inc.’s own tally for this item (“5. Shareholder proposal to Adopt Adopt An Independent Chair Policy”): 1,015,206,372 for, 2,509,042,021 against — failed, per its Form 8-K filed April 27, 2026 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “Proposal 5: The shareholder proposal to Adopt Adopt An Independent Chair Policy was not approved based upon the following votes”
Support: 29% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Pfizer Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Require Independent Board Chair” (6 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 233 asset managers below reported 149,821,325 for, 1,106,705,129 against, 2,747,869 abstained, 21,894 not voted, 133,221 unknown.

AGAINST
FOR: 149,821,325AGAINST: 1,106,705,129ABSTAIN: 2,747,869UNKNOWN: 133,221NOT VOTED: 21,894
Largest asset managers voting on “Adopt an Independent Chair Policy” at Pfizer Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard25,596,469487,897,408 1550Against
BlackRock165,997170,643,004 00Against
Fidelity1,779,400117,264,950 00Against
State Street17,00966,814,116 00Against
Charles Schwab9,75241,130,312 00Against
MFS033,995,774 00Against
Invesco020,894,350 00Against
Dimensional019,353,920 00Against
First Trust018,739,136 00Against
Capital Group17,959,8780 00For
Franklin Custodian Funds17,000,0000 00For
Pacer Funds Trust016,351,630 00Against
Hartford14,606,3910 00For
TIAA012,223,514 00Against
Federated Hermes10,850,0370 00For
Jackson National2,661,5216,655,542 00Mixed
MASTER INVESTMENT PORTFOLIO08,775,049 00Against
Columbia Threadneedle8,640,3880 00For
BNY Mellon5,069,3791,170,286 00Mixed
Neuberger Berman5,858,3610 00For
T. Rowe Price04,936,691 00Against
SEI4,756,2210 00For
Six Circles Trust04,675,319 00Against
Voya04,509,001 00Against
WisdomTree04,217,023 00Against

Showing the 25 largest of 233 asset managers. All 233 are in the interactive database (link above).

Not shown here: this season’s fund filings also report 1 item from the meeting of April 25, 2024, which belongs to the 2023-2024 season; 1 item from the meeting of April 24, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest Pfizer Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 5,686,267,431 shares outstanding at the time of that meeting.

Fund voting reports: top Pfizer Inc. shareholders by shares voted on “Advisory approval of named executive officer compensation”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 9.03%
2BlackRock 3.00%
3Fidelity 2.09%
4State Street 1.18%
5Charles Schwab 0.72%
6MFS 0.60%
7Invesco 0.37%
8Dimensional 0.34%
9First Trust 0.33%
10Capital Group 0.32%
Institutional-manager reports: top Pfizer Inc. shareholders by shares voted on “Advisory approval of named executive officer compensation”, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 4.35%
2State Street 2.96%
3GEODE CAPITAL MANAGEMENT, LLC 2.32%
4Fisher Asset Management, LLC 1.55%
5MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.13%
6Vanguard 1.04%
7Northern Trust 0.92%
8Charles Schwab 0.89%
9Wellington 0.78%
10Amundi 0.76%

Reported Pfizer Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Pfizer Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock498,257,550 8.76%Form 13F, quarter ended March 31, 2026
State Street301,589,865 5.30%Form 13F, quarter ended March 31, 2026
Morgan Stanley89,113,604 1.57%Form 13F, quarter ended March 31, 2026
Northern Trust62,026,552 1.09%Form 13F, quarter ended March 31, 2026
BNY Mellon53,879,900 0.95%Form 13F, quarter ended March 31, 2026
Charles Schwab51,891,636 0.91%Form 13F, quarter ended March 31, 2026
Wellington Management49,916,961 0.88%Form 13F, quarter ended March 31, 2026
Goldman Sachs49,810,156 0.88%Form 13F, quarter ended March 31, 2026
Pfizer Inc.22,032,040 0.39%Schedule 13D, filed February 13, 2026
Pfizer Inc. (IRS Identification No.: 13-5315170)3,442,940 0.06%Schedule 13G, filed May 12, 2026

Percentages above are of 5,686,267,431 shares outstanding, as reported by Pfizer Inc. on its Form 10-K dated February 19, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Pfizer Inc.'s shareholder meeting held April 23, 2026, in the 2025-2026 proxy season, 1,581 asset managers reported votes on at least one of its 16 ballot items in their SEC Form N-PX filings, covering 19,278 separate fund positions. On the most widely held item on that ballot — Advisory approval of named executive officer compensation — Pfizer Inc.'s filing reports the proposal as approved, with 88% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Pfizer Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on April 27, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Pfizer Inc.’s 10-K dated February 19, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Pfizer Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Pfizer (PFE) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/pfizer-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.